WHO IS SAM MIRON

The co-founder and CEO of Genogenics Labs, a biotechnology company specializing in pharmaceutical-grade peptides, NAD, and vitamin formulations engineered for human optimization. With over 20 years in biotech and pharmaceutical process design for companies like Amgen, Genentech, and Bayer, Sam combines advanced peptide engineering, genomics, and AI-driven research to create next-generation solutions for longevity and cellular repair. His mission is to make safe, clinically validated peptide therapy accessible to all who seek to enhance performance, recovery, and healthspan.

Peptides are one of the most misunderstood—and overhyped—tools in modern biohacking. CEO of Genogenics Labs, reveal the truth about peptides: what works, what’s dangerous, and what’s next in longevity medicine.

You’ll discover how FDA-approved, pharmaceutical-grade peptides differ from online “research” versions, why purity and sourcing are non-negotiable, and how next-generation delivery methods like exosomes and PEGylation are changing the game for recovery, performance, and anti-aging.

This conversation will open your eyes to how peptide therapy—when done correctly—can help you heal faster, age slower, and unlock new levels of human potential.

If you’re serious about health optimization, biohacking, and longevity, watch before trying anything on your own.